Sardine peptide with angiotensin i-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 10, 2009, Pages 2203-2209

  Otani, Lila ^a   Ninomiya, Toshio ^b   Murakami, Megumi ^a   Osajima, Katsuhiro ^b   Kato, Hisanori ^c   Murakami, Tetsuo ^a  

^a KINKI UNIVERSITY   (Japan)

^b Senmi Ekisu Co   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin I converting enzyme; Bood glucose; Sardine peptide; Stroke prone spontaneously hypertensive rats

Indexed keywords

ACE INHIBITORS; ACE-INHIBITORY; ANGIOTENSIN I-CONVERTING ENZYME; BLOOD GLUCOSE; BLOOD GLUCOSE LEVEL; BOOD GLUCOSE; CONTROL GROUPS; EXPERIMENTAL GROUPS; GLUCOSE TOLERANCE; INHIBITORY ACTIVITY; PLASMA INSULIN LEVELS; RAT STRAINS; SARDINE MUSCLE; SARDINE PEPTIDE; SPONTANEOUSLY HYPERTENSIVE RATS; STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS; TAP WATER;

AMINES; BLOOD; ENZYME ACTIVITY; ENZYMES; PEPTIDES; RATS;

GLUCOSE;

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; DRUG EFFECT; FISH; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; KIDNEY DISEASE; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; CARDIOMEGALY; FISHES; HYPERGLYCEMIA; HYPERTENSION; KIDNEY DISEASES; MALE; ORGAN SIZE; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; STROKE;

RATTUS;

EID: 70350451409     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90311     Document Type: Article

References (47)

1. Corry DB and Tuck ML, Am. J. Nephrol., 16, 223-236 (1996).
2. Sowers JR, Epstein M, and Frohlich ED, Hypertension, 37, 1053-1059 (2001).
3. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, JAMA, 288, 2981-2997 (2002).
4. Iimura O, Hypertens. Res., 19 (Suppl 1), S1-S8 (1996).
5. Strahorn P, Graham D, Charchar FJ, Sattar N, Mcbride MW, and Dominiczak AF, J. Hypertens., 23, 2179-2186 (2005).
6. Yamori Y, Ohtaka M, Ueshima H, Nara Y, Horie R, Shimamoto T, and Komachi Y, Jpn. Circ. J., 42, 841-847 (1978).
7. James DJ, Cairns F, Salt IP, Murphy GJ, Dominiczak AF, Connell JM, and Gould GW, Diabetes, 50, 2148-2156 (2001).
8. Collison M, James DJ, Graham D, Holman GD, Connell JM, Dominiczak AF, Gould GW, and Salt IP, Diabetologia, 48, 539-546 (2005).
9. Dzau VJ, Circulation, 77, I, 4-13 (1988).
10. Lavoie JL and Sigmund CD, Endocrinology, 144, 2179-2183 (2003).
11. No authors listed, Lancet, 355, 253-259 (2000).
12. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, and Dagenais G, N. Engl. J. Med., 342, 145-153 (2000).
13. Rao RH, Am. J. Hypertens., 7, 655-660 (1994).
14. Folli F, Saad MJA, Velloso L, and Hansen H, Exp. Clin. Endocrinol. Diabetes, 107, 133-139 (1999).
15. Matsui T, Matsufuji H, Seki E, Osajima K, Nakashima M, and Osajima Y, Biosci. Biotechnol. Biochem., 57, 922-925 (1993).
16. Kawasaki T, Seki E, Osajima K, Yoshida M, Asada K, Matsui T, and Osajima Y, J. Hum. Hypertens., 14, 519-523 (2000).
17. Matsui T, Hayashi A, Tamaya K, Matsumoto K, Kawasaki T, Murakami K, and Kimoto K, Clin. Exp. Pharmacol. Physiol., 30, 262-265 (2003).
18. Matsui T, Imamura M, Oka H, Osajima K, Kimoto K, Kawasaki T, and Matsumoto K, J. Pept. Sci., 10, 535-545 (2004).
19. Matsufuji H, Matsui T, Seki E, Osajima K, Nakashima M, and Osajima Y, Biosci. Biotechnol. Biochem., 58, 2244-2245 (1994).
20. Seki E, Osajima K, Matsui T, and Osajima Y, Nippon Shokuhin Koougyoukai Kaishi (in Japanese), 40, 783-791 (1993).
21. Seki E, Osajima K, Matsufuji H, Matsui T, and Osajima Y, Nippon Shokuhinkagaku Koougyoukai Kaishi (in Japanese), 43, 967-969 (1996).
22. Horiuchi M, Fujimura K, Terashima T, and Iso T, J. Chromatogr., 233, 123-130 (1982).
23. Collison M, Glazier AM, Graham D, Morton JJ, Dominiczak MH, Aitman TJ, Connell JM, Gould GW, and Dominiczak AF, Diabetes, 49, 2222-2226 (2000).
24. Fukushima M, Suzuki H, and Seino Y, Diabetes Res. Clin. Pract., 66 (Suppl 1), S37-S43 (2004).
25. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, and Tominaga Y, Diabetes Care, 20, 1562-1568 (1997).
26. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, Van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, and Weber M, Am. J. Cardiol., 88, 1L-20L (2001).
27. Leung PS and Carlsson PO, J. Mol. Endocrinol., 26, 155-164 (2001).
28. Lai FM, Tanikella T, Herzlinger H, and Cervoni P, Eur. J. Pharmacol., 67, 97-99 (1980).
29. Levens NR, Peach MJ, Vaughan ED, Weed WC, and Carey RM, Endocrinology, 108, 536-544 (1981).
30. Kurosawa Y, Katoh M, Doi H, and Narita H, J. Cardiovasc. Pharmacol., 39, 600-609 (2002).
31. Murakami T, Soga M, Mitsunaga T, Yoshizumi H, and Ito H, Clin. Exp. Pharmacol. Physiol., 21, 453-461 (1994).
32. Fernandez-Alfonso MS, Kreutz R, Zeh K, Liu Y, Ganten D, and Paul M, Hypertension, 24, 280-286 (1994).
33. Takai S, Sakonjo H, and Miyazaki M, Hypertens. Res., 24, 559-564 (2001).
34. Seki E, Osajima K, Matsufuji H, Matsui T, and Osajima Y, Nippon Nogeikagaku Kaishi (in Japanese), 69, 1013-1020 (1995).
35. Gillespie EL, White CM, Kardas M, Lindberg M, and Coleman CI, Diabetes Care, 28, 2261-2266 (2005).
36. Mancia G, Grassi G, and Zanchetti A, J. Hypertens., 24, 3-10 (2006).
37. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, and Krekler M, Hypertension, 38, 884-890 (2001).
38. Shiuchi T, Iwai M, Li HS, Wu L, Min LJ, Li JM, Okumura M, Cui TX, and Horiuchi M, Hypertension, 43, 1003-1010 (2004).
39. Rizzoni D, Pasini E, Flati V, Rodella LF, Paiardi S, Assanelli D, De Ciuceis C, Porteri E, Boari GE, Rezzani R, Speca S, Favero G, Martinotti S, Toniato E, Platto C, and Agabiti-Rosei E, J. Hypertens., 26, 1595-1601 (2008).
40. Velliquette RA and Ernsberger P, J. Pharmacol. Exp. Ther., 307, 1104-1111 (2003).
41. Tabbi-Anneni I, Buchanan J, Cooksey RC, and Abel ED, Endocrinology, 149, 4043-4050 (2008).
42. Tikellis C, Cooper ME, and Thomas MC, Int. J. Biochem. Cell Biol., 38, 737-751 (2006).
43. Huang Z, Jansson L, and Sjoholm A, Biochem. Biophys. Res. Commun., 346, 26-32 (2006).
44. Huang Z, Jansson L, and Sjoholm A, Clin. Sci., 112, 69-76 (2007).
45. Hamaguchi R, Takemori K, Inoue T, Masuno K, and Ito H, Clin. Exp. Pharmacol. Physiol., 35, 1151-1155 (2008).
46. Schmieder RE, Am. J. Hypertens., 18, 720-730 (2005).
47. Carey RM and Siragy HM, Endocr. Rev., 24, 261-271 (2003).